Clinical Trial Update: A Study of the KIO-201 (Ocular Bandage Gel) for Improving Persistent Corneal Epithelial Defects [Phase 2]

View source ↗

Summary

Phase 2 trial of KIO-201 (Ocular Bandage Gel) for persistent corneal epithelial defects has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Corneal Epithelial Defect

Drugs mentioned

• KIO-201 (Ocular Bandage Gel) (KIO-201)

Snippet

Sponsor: Kiora Pharmaceuticals, Inc. | Conditions: Persistent Corneal Epithelial Defect | Phase 2 | Status: COMPLETED | Results posted: 2024-04-03